The CXCR4 antagonist AMD3100 mobilizes a more primitive subset of CD34+cells than G-CSF

被引：0
|
作者：
Seeger, T
Veldwijk, M
Bridger, G
Calandra, G
Goldschmidt, H
Ho, A
Fruehauf, S
机构：
[1] Univ Heidelberg, Dept Internal Med 5, Heidelberg, Germany
[2] German Canc Res Ctr, Dept E0120, D-6900 Heidelberg, Germany
[3] AnorMED, Langley, BC, Canada
来源：
BLOOD | 2005年 / 106卷 / 11期
关键词：
D O I：
10.1182/blood.V106.11.1969.1969
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
1969
引用
收藏
页码：558A / 558A
页数：1
相关论文
共 50 条
  • [21] A pharmacokinetic/pharmacodynamic profile of the CXCR4 antagonist AMD3100 for the mobilization of hematopoietic progenitor cells.
    Lack, NA
    Dale, DC
    Calandra, G
    MacFarland, RT
    Badel, K
    Liles, WC
    BLOOD, 2003, 102 (11) : 115A - 115A
  • [22] CXCR4 antagonist AMD3100 attenuates colonic damage in mice with experimental colitis
    Xia, Xian-Ming
    Wang, Fang-Yu
    Xu, Wen-An
    Wang, Zhen-Kai
    Liu, Jiong
    Lu, You-Ke
    Jin, Xin-Xin
    Lu, Heng
    Shen, Yun-Zhu
    WORLD JOURNAL OF GASTROENTEROLOGY, 2010, 16 (23) : 2873 - 2880
  • [23] CXCR4 antagonist AMD3100 attenuates colonic damage in mice with experimental colitis
    Xian-Ming Xia
    World Journal of Gastroenterology, 2010, 16 (23) : 2873 - 2880
  • [24] AMD3100, a CxCR4 antagonist, attenuates allergic lung inflammation and airway Hyperreactivity
    Lukacs, NW
    Berlin, A
    Schols, D
    Skerlj, RT
    Bridger, GJ
    AMERICAN JOURNAL OF PATHOLOGY, 2002, 160 (04): : 1353 - 1360
  • [25] Increased sensitivity to bortezomib after mobilization of multiple myeloma cells with the CXCR4 antagonist AMD3100
    Wemeau, Mathieu
    Balkaran, Sandy
    Leleu, Xavier
    HEMATOLOGIE, 2009, 15 (03): : 194 - 196
  • [26] The CXCR4 Antagonist AMD3100 Has Dual Effects on Survival and Proliferation of Myeloma Cells In Vitro
    Kim, Ha-Yon
    Hwang, Ji-Young
    Kim, Seong-Woo
    Lee, Hyo-Jin
    Yun, Hwan-Jung
    Kim, Samyong
    Jo, Deog-Yeon
    CANCER RESEARCH AND TREATMENT, 2010, 42 (04): : 225 - 234
  • [27] Evaluation of the phenotype and GVHD-inducing potential of splenic T cells isolated from G-CSF, AMD3100, or G-CSF and AMD3100 pretreated allogeneic donors
    Rettig, M
    Holt, M
    Liu, FL
    Ritchey, J
    Link, D
    Bridger, G
    DiPersio, J
    BLOOD, 2005, 106 (11) : 389B - 390B
  • [28] CXCR4 Antagonist AMD3100 Accelerates Impaired Wound Healing in Diabetic Mice
    Nishimura, Yukihide
    Ii, Masaaki
    Qin, Gangjian
    Hamada, Hiromichi
    Asai, Jun
    Takenaka, Hideya
    Sekiguchi, Haruki
    Renault, Marie-Ange
    Jujo, Kentaro
    Katoh, Norito
    Kishimoto, Saburo
    Ito, Aiko
    Kamide, Christine
    Kenny, John
    Millay, Meredith
    Misener, Sol
    Thorne, Tina
    Losordo, Douglas W.
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2012, 132 (03) : 711 - 720
  • [29] CXCR4 receptor antagonist, AMD3100, is a potent inhibitor of HIV infection.
    De Clercq, E
    Schols, D
    Bridger, G
    Henson, G
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2001, 221 : U5 - U5
  • [30] Rapid mobilization of murine and human hematopoietic stem and progenitor cells with AMD3100, a CXCR4 antagonist
    Broxmeyer, HE
    Orschell, CM
    Clapp, DW
    Hangoc, G
    Cooper, S
    Plett, PA
    Liles, WC
    Li, XX
    Graham-Evans, B
    Campbell, TB
    Calandra, G
    Bridger, G
    Dale, DC
    Srour, EF
    JOURNAL OF EXPERIMENTAL MEDICINE, 2005, 201 (08): : 1307 - 1318
12345